KYMR
Price
$89.68
Change
+$1.87 (+2.13%)
Updated
Dec 12 closing price
Capitalization
7.17B
68 days until earnings call
Intraday BUY SELL Signals
TERN
Price
$45.00
Change
-$2.09 (-4.44%)
Updated
Dec 12 closing price
Capitalization
4.89B
108 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs TERN

Header iconKYMR vs TERN Comparison
Open Charts KYMR vs TERNBanner chart's image
Kymera Therapeutics
Price$89.68
Change+$1.87 (+2.13%)
Volume$1.86M
Capitalization7.17B
Terns Pharmaceuticals
Price$45.00
Change-$2.09 (-4.44%)
Volume$6.88M
Capitalization4.89B
KYMR vs TERN Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. TERN commentary
Dec 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and TERN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 14, 2025
Stock price -- (KYMR: $87.81 vs. TERN: $47.09)
Brand notoriety: KYMR and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 147% vs. TERN: 134%
Market capitalization -- KYMR: $7.17B vs. TERN: $4.89B
KYMR [@Biotechnology] is valued at $7.17B. TERN’s [@Biotechnology] market capitalization is $4.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while TERN’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 3 bearish.
  • TERN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KYMR and TERN are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а +32.58% price change this week, while TERN (@Biotechnology) price change was +73.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

TERN is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($7.17B) has a higher market cap than TERN($4.9B). TERN YTD gains are higher at: 750.000 vs. KYMR (118.270). TERN has higher annual earnings (EBITDA): -107.87M vs. KYMR (-286.52M). KYMR has more cash in the bank: 506M vs. TERN (296M). TERN has less debt than KYMR: TERN (1.03M) vs KYMR (84M). KYMR has higher revenues than TERN: KYMR (43.7M) vs TERN (0).
KYMRTERNKYMR / TERN
Capitalization7.17B4.9B147%
EBITDA-286.52M-107.87M266%
Gain YTD118.270750.00016%
P/E RatioN/AN/A-
Revenue43.7M0-
Total Cash506M296M171%
Total Debt84M1.03M8,163%
TECHNICAL ANALYSIS
Technical Analysis
KYMRTERN
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIOVX20.670.21
+1.03%
Causeway International Opps Inv
PLARX12.500.11
+0.89%
Principal SmallCap Value II R5
EIERX22.150.15
+0.68%
Eaton Vance Stock I
NEWCX92.960.18
+0.19%
American Funds New World C
GVIRX18.27-1.00
-5.19%
Goldman Sachs US Eq Div and Premium Inv

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-2.31%
NRIX - KYMR
62%
Loosely correlated
-2.75%
WVE - KYMR
55%
Loosely correlated
-17.20%
OCUL - KYMR
54%
Loosely correlated
-4.80%
VERA - KYMR
52%
Loosely correlated
+3.79%
GPCR - KYMR
51%
Loosely correlated
-2.18%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with GPCR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+5.56%
GPCR - TERN
43%
Loosely correlated
-2.18%
ELVN - TERN
42%
Loosely correlated
-6.94%
KYMR - TERN
40%
Loosely correlated
-2.31%
WVE - TERN
40%
Loosely correlated
-17.20%
OCUL - TERN
40%
Loosely correlated
-4.80%
More